Abstract
A 46-year-old female presented with a 1 year history of persistent papules on her nose and around her mouth. She had been diagnosed with adult acne by her primary care physician and treated with topical clindamycin with no success. The facial lesions were asymptomatic; however, she notes mild fatigue, occasional dyspnea on exertion, and a mild cough.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. J Am Acad Dermatol. 2012;66(5):699.e1–18. quiz 717–8.
Rybicki BA, Major M, Popovich Jr J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145(3):234–41.
Guss L, Ghazarian S, Daya N, Okoye G. Sarcoidosis in African Americans. Austin J Dermatol. 2014;1(6):1028.
Heath CR, David J, Taylor SC. Sarcoidosis: are there differences in your skin of color patients? J Am Acad Dermatol. 2012;66(1):121.e1–14.
Edmondstone WM, Wilson AG. Sarcoidosis in Caucasians, Blacks and Asians in London. Br J Dis Chest. 1985;79(1):27–36.
Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S, et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax. 2011;66(2):144–50.
Yee AM, Pochapin MB. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med. 2001;135(1):27–31.
McKinley-Grant L, Warnick M, Singh S. Cutaneous manifestations of systemic diseases. In: Kelly A, Taylor S, editors. Dermatology for Skin of Color. China: McGraw-Hill Companies, Inc.; 2009.
Cozier Y, Ruiz-Narvaez E, McKinnon C, Berman J, Rosenberg L, Palmer J. Replication of genetic loci for sarcoidosis in US black women: data from the Black Women’s Health Study. Hum Genet. 2013;132(7):803–10.
Pietinalho A, Hiraga Y, Hosoda Y, Lofroos AB, Yamaguchi M, Selroos O. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis. 1995;12(1):61–7.
Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol. 2001;137(1):69–73.
Jones E, Callen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J Am Acad Dermatol. 1990;23(3 Pt 1):487–9.
Webster GF, Razsi LK, Sanchez M, Shupack JL. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol. 1991;24(3):451–4.
Crommelin HA, Vorselaars AD, van Moorsel CH, Korenromp IH, Deneer VH, Grutters JC. Anti-TNF therapeutics for the treatment of sarcoidosis. Immunotherapy. 2014;6(10):1127–43.
Scailteux LM, Guedes C, Polard E, Perdriger A. Sarcoidosis after adalimumab treatment in inflammatory rheumatic diseases: a report of two cases and literature review. Presse Med. 2015;44(1):4–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Wheat, C.M., Okoye, G.A., Love, P.B. (2016). Sarcoidosis. In: Love, P., Kundu, R. (eds) Clinical Cases in Skin of Color. Clinical Cases in Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-23615-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-23615-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23614-8
Online ISBN: 978-3-319-23615-5
eBook Packages: MedicineMedicine (R0)